Many types of cancer could be more easily treated if they were detected at an earlier stage. MIT researchers have now developed an imaging system, named “DOLPHIN,” which could enable them to find tiny tumors, as small as a couple of hundred cells, deep within the body.
In a new study, the researchers used their imaging system, which relies on near-infrared light, to track a 0.1-millimeter fluorescent probe through the digestive tract of a living mouse. They also showed that they can detect a signal to a tissue depth of 8 centimeters, far deeper than any existing biomedical optical imaging technique.
The researchers hope to adapt their imaging technology for early diagnosis of ovarian and other cancers that are currently difficult to detect until late stages.
“We want to be able to find cancer much earlier,” says Angela Belcher, the James Mason Crafts Professor of Biological Engineering and Materials Science at MIT and a member of the Koch Institute for Integrative Cancer Research, and the newly-appointed head of MIT’s Department of Biological Engineering. “Our goal is to find tiny tumors, and do so in a noninvasive way.”
Belcher is the senior author of the study, which appears in the March 7 issue of Scientific Reports. Xiangnan Dang, a former MIT postdoc, and Neelkanth Bardhan, a Mazumdar-Shaw International Oncology Fellow, are the lead authors of the study. Other authors include research scientists Jifa Qi and Ngozi Eze, former postdoc Li Gu, postdoc Ching-Wei Lin, graduate student Swati Kataria, and Paula Hammond, the David H. Koch Professor of Engineering, head of MIT’s Department of Chemical Engineering, and a member of the Koch Institute.
Existing methods for imaging tumors all have limitations that prevent them from being useful for early cancer diagnosis. Most have a tradeoff between resolution and depth of imaging, and none of the optical imaging techniques can image deeper than about 3 centimeters into tissue. Commonly used scans such as X-ray computed tomography (CT) and magnetic resonance imaging (MRI) can image through the whole body; however, they can’t reliably identify tumors until they reach about 1 centimeter in size.
Belcher’s lab set out to develop new optical methods for cancer imaging several years ago, when they joined the Koch Institute. They wanted to develop technology that could image very small groups of cells deep within tissue and do so without any kind of radioactive labeling.
Near-infrared light, which has wavelengths from 900 to 1700 nanometers, is well-suited to tissue imaging because light with longer wavelengths doesn’t scatter as much as when it strikes objects, which allows the light to penetrate deeper into the tissue. To take advantage of this, the researchers used an approach known as hyperspectral imaging, which enables simultaneous imaging in multiple wavelengths of light.
The researchers tested their system with a variety of near-infrared fluorescent light-emitting probes, mainly sodium yttrium fluoride nanoparticles that have rare earth elements such as erbium, holmium, or praseodymium added through a process called doping. Depending on the choice of the doping element, each of these particles emits near-infrared fluorescent light of different wavelengths.
Using algorithms that they developed, the researchers can analyze the data from the hyperspectral scan to identify the sources of fluorescent light of different wavelengths, which allows them to determine the location of a particular probe. By further analyzing light from narrower wavelength bands within the entire near-IR spectrum, the researchers can also determine the depth at which a probe is located. The researchers call their system “DOLPHIN”, which stands for “Detection of Optically Luminescent Probes using Hyperspectral and diffuse Imaging in Near-infrared.”
To demonstrate the potential usefulness of this system, the researchers tracked a 0.1-millimeter-sized cluster of fluorescent nanoparticles that was swallowed and then traveled through the digestive tract of a living mouse. These probes could be modified so that they target and fluorescently label specific cancer cells.
“In terms of practical applications, this technique would allow us to non-invasively track a 0.1-millimeter-sized fluorescently-labeled tumor, which is a cluster of about a few hundred cells. To our knowledge, no one has been able to do this previously using optical imaging techniques,” Bardhan says.
The researchers also demonstrated that they could inject fluorescent particles into the body of a mouse or a rat and then image through the entire animal, which requires imaging to a depth of about 4 centimeters, to determine where the particles ended up. And in tests with human tissue-mimics and animal tissue, they were able to locate the probes to a depth of up to 8 centimeters, depending on the type of tissue.
Guosong Hong, an assistant professor of materials science and engineering at Stanford University, described the new method as “game-changing.”
“This is really amazing work,” says Hong, who was not involved in the research. “For the first time, fluorescent imaging has approached the penetration depth of CT and MRI, while preserving its naturally high resolution, making it suitable to scan the entire human body.”
This kind of system could be used with any fluorescent probe that emits light in the near-infrared spectrum, including some that are already FDA-approved, the researchers say. The researchers are also working on adapting the imaging system so that it could reveal intrinsic differences in tissue contrast, including signatures of tumor cells, without any kind of fluorescent label.
In ongoing work, they are using a related version of this imaging system to try to detect ovarian tumors at an early stage. Ovarian cancer is usually diagnosed very late because there is no easy way to detect it when the tumors are still small.
“Ovarian cancer is a terrible disease, and it gets diagnosed so late because the symptoms are so nondescript,” Belcher says. “We want a way to follow recurrence of the tumors, and eventually a way to find and follow early tumors when they first go down the path to cancer or metastasis. This is one of the first steps along the way in terms of developing this technology.”
The researchers have also begun working on adapting this type of imaging to detect other types of cancer such as pancreatic cancer, brain cancer, and melanoma.
The Latest on: Imaging system
via Google News
The Latest on: Imaging system
- Experimental blood pumping system restores some function to brains of dead pigs on April 17, 2019 at 11:05 am
they applied the experimental BrainEx system, which pumps a blood-substitution fluid carrying nutrients and oxygen plus stabilizing compounds and activity blockers into each brain's main arteries. ... […]
- Medical Imaging Market 2019: Full in-Depth Analysis by Regional Outlook, Growth, Trend, Share, Size and Forecast to 2022 on April 17, 2019 at 10:07 am
Apr 17, 2019 (AB Digital via COMTEX) -- Advancements in technology have introduced medical imaging systems that can show diffuse and focal pathologies in a variety of organs. Increasing prevalence of ... […]
- Avinger nabs new patent in U.S. related OCT intravascular imaging system; shares up 11% premarket on April 17, 2019 at 6:09 am
The USPTO has issued Avinger (NASDAQ:AVGR) a new patent related to the Company's optical coherence tomography (OCT) intravascular imaging system. The Patent No. 10,244,934, titled "Atherectomy ... […]
- Medical Digital Imaging Systems Market Clinical Area Segmentation 2019 to 2025 on April 17, 2019 at 5:59 am
This research report aims at answering various aspects of the global Medical Digital Imaging Systems market with the help of the key factors driving the market, the restraints, and the challenges that ... […]
- Widefield Imaging Systems Market Analysis and Forecast to 2026 by Leading Players Like: Heidelberg Engineering, ZEISS Int, Centervue, Optos Plc on April 17, 2019 at 2:47 am
New York, NY -- (SBWIRE) -- 04/17/2019 -- The latest report Widefield Imaging Systems discusses everything a business owner needs to know about the Widefield Imaging Systems market for the forecast ... […]
- Dutch Deventer Hospital Selects Sectra as its Imaging IT Vendor on April 16, 2019 at 11:55 pm
The solution's track record of high system availability and its ease of ... is a key component of Sectra's enterprise imaging solution and enables consolidation of image handling, while ensuring ... […]
- Workshop explores the future of artificial intelligence in medical imaging on April 16, 2019 at 10:07 pm
Langlotz, M.D., Ph.D. Dr. Langlotz is a professor of radiology and biomedical informatics, director of the Center for Artificial Intelligence in Medicine and Imaging, and associate chair for ... […]
- Global Hyperspectral Imaging Markets to 2023 by Technology, Camera System, Application and Region on April 16, 2019 at 2:51 am
Dublin, April 16, Apr 16, 2019 (GLOBE NEWSWIRE via COMTEX) -- Dublin, April 16, 2019 (GLOBE NEWSWIRE) -- The "Hyperspectral Imaging: Technologies and Global Markets to 2023" report has been added to ... […]
- Spectra open source biomedical imaging system affordable CATSCAN alternative on April 15, 2019 at 2:27 am
Mindseye Biomedical has created a new open source biomedical imaging system called Spectra which is both safe and easy to use now available to preorder via the Crowd Supply website price from $299 for ... […]
- Hyper Spectral Imaging System Market to Garner Noteworthy 8.4% CAGR till 2024 due to Identification of Cancerous Cells - TMR on April 4, 2019 at 4:30 am
ALBANY, New York, April 4, 2019 /PRNewswire/ -- The global hyper spectral imaging system market portrays a competitive and robust landscape, states Transparency Market Research. There are companies ... […]
via Bing News